Severe Infections after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Comparison of Cord Blood Transplantation with Peripheral Blood and Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 7, 2006, Pages 734-748

  Parody, Rocío ^a   Martino, Rodrigo ^a   Rovira, Montserrat ^b   Vazquez, Lourdes ^c   Vázquez, María José ^c   de la Cámara, Rafael ^d   Blazquez, Cristina ^d   Fernández Avilés, Francesc ^b   Carreras, Enric ^b   Salavert, Miguel ^e   Jarque, Isidro ^e   Martín, Carmen ^f   Martínez, Francisco ^f   López, Javier ^g   Torres, Antonio ^f   Sierra, Jorge ^a   Sanz, Guilllermo F ^e  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cord blood; Severe infections; Unrelated hematopoietic stem cell transplantation

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THIOTEPA; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CELL COUNT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DONOR SELECTION; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOSIS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BACTERIAL INFECTIONS; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; INFECTION; MALE; MIDDLE AGED; MYCOSES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33745161075     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.03.007     Document Type: Article

References (44)

1. Atkinson K., Dodds A.J., Concannon A.J., Miliken S., et al. Unrelated volunteer bone marrow transplantation. initial experience at St Vincent's Hospital, Sydney. Aust N Z J Med 23 (1993) 450-457
2. Marks D.I., Cullis J.O., Ward K.N., et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 119 (1993) 207-214
3. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
4. Williamson E.C., Millar M.R., Steward C.G., et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 104 (1999) 560-568
5. Saavedra S., Jarque I., Sanz G.F., et al. Infectious complications in patients undergoing unrelated donor bone marrow transplantation. experience from a single institution. Clin Microbiol Infect 8 (2002) 725-733
6. van Kraaij M.G., Verdonck L.F., Rozenberg-Arska M., and Dekker A.W. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation. a comparison of incidence. Bone Marrow Transplant 30 (2002) 303-309
7. Mitchell A.E., Derrington P., Turner P., Hunt L.P., Oakhill A., and Marks D.I. Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT). risk factors, prophylaxis, therapy and outcome. Bone Marrow Transplant 33 (2004) 303-310
8. McCann S., Byrne J.L., Rovira M., et al., Infectious Diseases Working Party of the EBMT. Outbreaks of infectious diseases in stem cell transplant units. a silent cause of death for patients and transplant programmes. Bone Marrow Transplant 33 (2004) 519-529
9. Remberger M., Ringden O., Blau I.W., et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 98 (2001) 1739-1745
10. Yoo J.H., Lee D.G., Choi S.M., et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 34 (2004) 497-504
11. Saavedra S., Sanz G.F., Jarque I., et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant 30 (2002) 937-943
12. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
13. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
14. Takahashi S., Iseki T., Ooi J., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematological malignancies. Blood 104 (2004) 3813-3820
15. Glukman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant. guidelines for donor choice. Exp Hematol 32 (2004) 397-407
16. Barker J.N., Hough R.E., van Burik J.A., et al. Serious infections after unrelated donor transplantation in 136 children. impact of stem cell source. Biol Blood Marrow Transplant 11 (2005) 362-370
17. Narimatsu H., Matsumura T., Kami M., et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 11 (2005) 429-436
18. Ascioglu S., Rex J.H., de Pauw B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants. an international consensus. Clin Infect Dis 34 (2002) 7-14
19. Ljungman P., Reusser P., de la Cámara R., et al. Management of CMV infections. recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant 33 (2004) 1075-1081
20. Yoshikawa T. Human herpesvirus 6 infection in hematopoietic stem cell transplant patients. Br J Haematol 124 (2004) 421-432
21. Wagner H.J., Rooney C.M., and Heslop H.E. Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8 (2002) 1-8
22. Ljungman P., Ribaud P., Eyrich M., et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation. a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 31 (2003) 481-486
23. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
24. Sullivan K.M., Agura E., Anasetti C., et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28 (1991) 250-259
25. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant 28 (2001) 909-915
26. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling. Bone Marrow Transplant 28 (2001) 1001-1011
27. Martino R., Gomez L., Pericas R., et al. Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis 19 (2000) 320-323
28. Martino R., Santamaria A., Muñoz L., et al. Bacteremia by gram-negative bacilli in patients with hematologic malignancies. Comparison of the clinical presentation and outcome of infections by enterobacteria and non-glucose-fermenting gram-negative bacilli. Acta Haematol 102 (1999) 7-11
29. Ochs L., Shu X.O., Miller J., et al. Late infections after allogeneic bone marrow transplantations. comparison of incidence in related and unrelated donor transplant recipients. Blood 86 (1995) 3979-3986
30. Pavletic S.Z., Carter S.L., Kernan N.A., et al. Influence of T-cell depletion on chronic graft-versus-host disease. results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood 106 (2005) 3308-3313
31. Cornetta K., Laughlin M., Carter S., et al. Umbilical cord blood transplantation in adults. results of the prospective Cord Blood Transplantation (COBLT). Biol Blood Marrow Transplant 11 (2005) 149-160
32. Carreras E., Jimenez M., Gomez-García V., et al. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 37 (2005) 33-40
33. Sanz G.F., Saavedra S., Planelles D., et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 98 (2001) 2332-2338
34. Ninin E., Milpied N., Moreau P., et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 33 (2001) 41-47
35. Hamza N.S., Lisgaris M., Yadavalli G., et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 124 (2004) 488-498
36. Fernandez M.N., Regidor C., Cabrera R., et al. Unrelated umbilical cord blood transplants in adults. early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 31 (2003) 535-544
37. Cabrera R., Krsnik I., Fores R., et al. Post-engraftment infections in adult patients transplanted with single cord blood units supported by co-infusion of mobilized purified hematopoietic stem cells from a third party donor. Blood 106 (2005) 3240
38. Kim D.H., Kim J.G., Sohn S.K., et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 125 (2004) 217-224
39. Storek J., Espino G., Dawson M.A., Storer B., Flowers M.E., and Maloney D.G. Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood 96 (2000) 3290-3293
40. Cordonnier C., Ribaud P., Herbrecht R., Milpied N., Valteau-Couanet D., Morgan C., Wade A., and Société Française de Greffe de Moelle et de Thérapie Cellulaire. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation. a 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis 42 (2006) 955-963
41. Kögler G., Enczmann J., Rocha V., Gluckman E., and Wernet P. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 36 (2005) 1033-1041
42. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation. HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104 (2004) 1923-1930
43. El Kassar N., Legouvello S., Joseph C.M., et al. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation. a single-institution retrospective study of 69 BMTs. Bone Marrow Transplant 27 (2001) 35-43
44. Barker J.N., Scaradavou A., Stevens C.E., and Rubinstein P. Analysis of 608 umbilical cord blood (UCB) transplants. HLA-match is a critical determinant of transplant-related mortality (TRM) in the post-engraftment period even in the absence of acute graft-vs-host disease (aGVHD). Blood 106 (2005) 303